The Humanities of Scientific Investment: Perspectives from Europe’s Top Biotech Hub

Jul 19, 2017

Sharon Vosmek, CEO of Silicon Valley-based fund Astia Angels, framed it as a key focus in the success of a biotech company in her keynote speech. “Investment, particularly early-stage, is personal,” she remarked. “It will never be about your pitch — our investment will be about us talking and about changing the world.”